Slide 1: Investor Presentation
Investor Presentation Presented by Rick Van Kirk, CEO
Slide 2: Safe Harbor Statement
Safe Harbor Statement Statements made during Pro - Dex’s presentation and its representative’s answers to questions that refer to Pro - Dex’s estimated or anticipated future results or other non - public historical facts are forward - looking statements, as are any statements its representatives mak
Slide 3: Investment Highlights
Investment Highlights 3 → High - value product pipeline → Strong long term relationships with dominant and strategic orthopedic OEMs → High value intellectual property → Increasing margins and considerable operating leverage → Stable core cash flow → Management team that can execute on new initiativ
Slide 4: Past to Present: Revenue, Share Price and Key Figures
Pro - Dex Past to Present 4 Revenue (in millions) PDEX Share Price Key Figures as of December 31, 2018 (2019 Q2) Employees 83 Shares Outstanding 4.1 m Float : 2.7m Avg Daily Volume (3 mos ): 30K Cash $8.9 m Debt : $4.9 m Book Value $17.0 m $50.0 m Mkt Cap 0 5 10 15 20 25 30 2009 2010 2011 2012 2013
Slide 5: Core Business
Pro - Dex Core Business 5 “ The interface between surgeons and patients. ” → Arthroscopic/ENT Shavers → Sagittal Saw Mechanisms → Craniomaxillofacial Drivers → Multifunction Handpieces → Robotic End Effectors → Engineering Services → QA/RA Services Pro - Dex has deployed smart drivers in CMF with 3
Slide 6: Surgical Power: Addressable Market
Surgical Power: Addressable Market $1.2 - 1.7bn 6 CMF Thoracic Shoulder Elbow Spine Hip Knee Extremities Global Orthopedic Devices Market Revenue CMF Extremities Elbow Shoulder Spine Hip Knee Total $ 29.2 bn Source: KOL Opinions, Company Annual Reports, Expert Interview, Investing Publications, TMR
Slide 7: TorqueDrive
TORQUEDRIVE 7 The software algorithm can be integrated across a family of products from small bone and CMF (MatrixPro) to large bone and trauma Our algorithms do not affect the operation of non drill/drive ancillary operations; for example sagittal saws, burrs, etc. Screws mapped and optimized to th
Slide 8: Small Bone: CMF, Thoracic, Extremities
Small Bone: CMF, Thoracic, Extremities 8 → Modular quick - swap capabilities for attachments → Patent filed on thoracic non - invasive attachment for anterior rib fixation with posterior approach → Early adopters have taken significant share Pro - Dex serves > 60% of the market (3 major customers) P
Slide 9: Trauma, Large Bone, Reconstructive
0 2 4 6 8 10 12 14 16 0 5 10 15 20 25 30 35 Trauma, Large Bone, Reconstructive 9 Prevention of cortical breach via tissue differentiation Screw seating torques significantly higher than Tissue Removal Torques → Adaptive Torque limiting does not affect application of non - driving applications → Rapi
Slide 10: High Potential Future Product Portfolio
High Potential Future Product Portfolio 10 → Negotiating potential partner for high value differentiated blade IP → Promising R&D developments and several provisional patents filed → Possible 3D VR third party application specific integration → Negotiating potential partner → Direct Sales Model → De
Slide 11: Management Team
Management Team 11 Jamie Rudy, Director of Business Development Rick Van Kirk, MBA, President & CEO 37 years experience – Pro - Dex, Unisys, Dynacast International, Comarco Angel Domingo, Director of Compliance and Engineering Systems 22 years experience – Pro - Dex, Spectrum, Chemicon , Watson Rick
Slide 12: Pro-Dex: Powered Surgical Solutions
Pro-DEX POWERED SURGICAL SOLUTIONS.